🔎 Trials Near Me

Akèy › Neuroblastom › North Carolina

Etid klinik pou Neuroblastom nan North Carolina

7 etid pou Neuroblastom ap chèche patisipan nan sit nan North Carolina.

Vil nan North Carolina

Tèks ofisyèl etid la (Anglè)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Mission Hospital, Asheville
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • ak 4 plis
Ap rekriteFaz 3
Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Levine Children's Hospital, Charlotte
Ap rekriteFaz 2
Jiska laj 22 · Tout sèks · Mizajou Sep 4, 2026 · NCT02559778

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

  • Duke University, Durham
Ap rekriteFaz 2
Laj 1 a 21 · Tout sèks · Mizajou Sep 3, 2026 · NCT06540963

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Mission Hospital, Asheville
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • ak 3 plis
Ap rekriteFaz 3
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Levine Children's Hospital, Charlotte
  • Duke University, Durham
Ap rekriteFaz 2
12 Months – 21 Years · Tout sèks · Mizajou Aug 12, 2026 · NCT05489887

SPEARHEAD-3 Pediatric Study

  • Duke University School of Medicine, Durham
Ap rekriteFaz 1/2
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
Ap rekriteFaz 1
18 Months · Tout sèks · Mizajou Mar 27, 2026 · NCT03721068

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.